| Mitochondrial mutations drive prostate cancer aggression JF Hopkins, VY Sabelnykova, J Weischenfeldt, R Simon, JA Aguiar, ... Nature communications 8 (1), 656, 2017 | 108 | 2017 |
| Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer’s disease R Alkallas, L Fish, H Goodarzi, HS Najafabadi Nature communications 8 (1), 909, 2017 | 93 | 2017 |
| Spatially mapping the immune landscape of melanoma using imaging mass cytometry D Moldoveanu, LA Ramsay, M Lajoie, L Anderson-Trocme, M Lingrand, ... Science immunology 7 (70), eabi5072, 2022 | 69 | 2022 |
| Translating a prognostic DNA genomic classifier into the clinic: retrospective validation in 563 localized prostate tumors E Lalonde, R Alkallas, MLK Chua, M Fraser, S Haider, A Meng, J Zheng, ... European urology 72 (1), 22-31, 2017 | 51 | 2017 |
| Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanoma R Alkallas, M Lajoie, D Moldoveanu, KV Hoang, P Lefrançois, M Lingrand, ... Nature Cancer 1 (6), 635-652, 2020 | 33 | 2020 |
| Melanomas with concurrent BRAF non-p. V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy S Rajkumar, D Berry, KA Heney, C Strong, LA Ramsay, M Lajoie, ... Cell Reports 39 (1), 2022 | 14 | 2022 |
| Pan-cancer analysis of mRNA stability for decoding tumour post-transcriptional programs G Perron, P Jandaghi, E Moslemi, T Nishimura, M Rajaee, R Alkallas, ... Communications Biology 5 (1), 851, 2022 | 9 | 2022 |
| The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma GS Karachaliou, R Alkallas, SB Carroll, C Caressi, D Zakria, NM Patel, ... BMC cancer 22, 1-14, 2022 | 5 | 2022 |
| A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation MM Drozdz, AS Doane, R Alkallas, G Desman, R Bareja, M Reilly, J Bang, ... Cell reports 40 (13), 2022 | 4 | 2022 |
| Publisher Correction: Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer’s disease R Alkallas, L Fish, H Goodarzi, HS Najafabadi Nature communications 9 (1), 4625, 2018 | 1 | 2018 |
| 646 A nuclear cAMP microdomain suppresses tumor growth by hippo pathway inactivation M Drozdz, AS Doane, R Alkallas, G Desman, R Bareja, M Reilly, J Bang, ... Journal of Investigative Dermatology 142 (8), S111, 2022 | | 2022 |
| Analysis of mRNA Dynamics Using RNA Sequencing Data R Alkallas, HS Najafabadi Neuronal Cell Death: Methods and Protocols, 129-150, 2022 | | 2022 |
| Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's disease (vol 8, 909, 2017) R Alkallas, L Fish, H Goodarzi, HS Najafabadi NATURE COMMUNICATIONS 9, 2018 | | 2018 |
